Suppr超能文献

来自DSM 29547菌株的食品酶毛霉胃蛋白酶的安全性评估。

Safety evaluation of the food enzyme mucorpepsin from strain DSM 29547.

作者信息

Lambré Claude, Barat Baviera José Manuel, Bolognesi Claudia, Cocconcelli Pier Sandro, Crebelli Riccardo, Gott David Michael, Grob Konrad, Lampi Evgenia, Mengelers Marcel, Mortensen Alicja, Rivière Gilles, Steffensen Inger-Lise, Tlustos Christina, Van Loveren Henk, Vernis Laurence, Zorn Holger, Herman Lieve, Maia Joaquim, Kovalkovicova Natalia, Lunardi Simone, Liu Yi, Chesson Andrew

出版信息

EFSA J. 2022 Aug 11;20(8):e07457. doi: 10.2903/j.efsa.2022.7457. eCollection 2022 Aug.

Abstract

The food enzyme mucorpepsin (EC 3.4.23.23) is produced with the non-genetically modified strain DSM 29547 by Chr. Hansen. The food enzyme is free from viable cells of the production organism. It is intended to be used in dairy processing for cheese production. The dietary exposure to the food enzyme-total organic solids (TOS) was estimated to be up to 0.26 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by a repeated dose 90-day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 618 mg TOS/kg bw per day, the highest dose tested, which when compared with the estimated dietary exposure, results in a margin of exposure of at least 2,400. A search for similarity of the amino acid sequence of the food enzyme to known allergens was made and three matches were found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded but is considered low except for individuals sensitised to mustard proteins, but this risk will not exceed that of mustard consumption. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use.

摘要

食品酶毛霉胃蛋白酶(EC 3.4.23.23)由科汉森公司使用非转基因菌株DSM 29547生产。该食品酶不含生产生物体的活细胞。它拟用于乳制品加工以生产奶酪。据估计,欧洲人群通过饮食接触该食品酶的总有机固体(TOS)量高达每天0.26毫克TOS/千克体重。遗传毒性测试未表明存在安全问题。通过对大鼠进行为期90天的重复剂量口服毒性研究评估了全身毒性。专家小组确定未观察到有害作用水平为每天618毫克TOS/千克体重,这是测试的最高剂量,与估计的饮食接触量相比,得出的接触界限至少为2400。对该食品酶的氨基酸序列与已知过敏原进行了相似性搜索,发现了三个匹配项。专家小组认为,在预期使用条件下,不能排除因饮食接触引起过敏致敏和激发反应的风险,但除对芥菜蛋白过敏的个体外,该风险被认为较低,且此风险不会超过食用芥菜的风险。根据所提供的数据,专家小组得出结论,在预期使用条件下,这种食品酶不会引起安全问题。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验